[ad_1] NEW YORK, Sept. 8, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Moderna, Inc. […]
Trending Stories
ICEYE to bring SAR satellites and information to Greece’s Nationwide Satellite tv for pc Range Challenge in collaboration with the Ecu Range Company
[ad_1] SAR satellites and information permit Greece to observe their disciplines of hobby and give a boost to their herbal crisis detection and maritime consciousness features. HELSINKI, Sept. 8, 2024 /PRNewswire/ — ICEYE, the worldwide chief […]
ICEYE to deliver SAR satellites and data to Greece’s National Satellite Space Project in collaboration with the European Space Agency
[ad_1] SAR satellites and data enable Greece to monitor their areas of interest and improve their natural catastrophe detection and maritime awareness capabilities. HELSINKI, Sept. 8, 2024 /PRNewswire/ — ICEYE, the global leader in synthetic aperture […]
Perioperative Ivonescimab (PD-1/VEGF) for NSCLC Demonstrated Clinically Significant Phase II Results, Presented in Oral Session at WCLC 2024
[ad_1] HONG KONG, Sept. 8, 2024 /PRNewswire/ — Akeso (9926. HK) announced that its internally developed PD-1/VEGF bispecific antibody ivonescimab showed clinically significant results from a Phase II study, either as a monotherapy or in […]
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show strong favorable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer
[ad_1] New longer-term data from the MARIPOSA study confirm superior outcomes of chemotherapy-free RYBREVANT® plus LAZCLUZE™ regimen compared to osimertinib monotherapy as first-line therapy Results from an interim analysis featured in late-breaker oral presentation at […]
